Search Results - "VEDELER, C"

Refine Results
  1. 1

    What women emphasise as important aspects of care in childbirth – an online survey by Vedeler, C, Nilsen, ABV, Blix, E, Downe, S, Eri, TS

    “…Objective To explore and describe what women who have given birth in Norway emphasise as important aspects of care during childbirth. Design The study is based…”
    Get full text
    Journal Article
  2. 2

    Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force by Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., Vedeler, C. A., Voltz, R., Verschuuren, J. J. G. M.

    Published in European journal of neurology (01-01-2011)
    “…Background:  Paraneoplastic neurological syndromes (PNS) almost invariably predate detection of the malignancy. Screening for tumours is important in PNS as…”
    Get full text
    Journal Article
  3. 3

    Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy by Olberg, H. K., Eide, G. E., Cox, R. J., Jul‐Larsen, Å., Lartey, S. L., Vedeler, C. A., Myhr, K.‐M.

    Published in European journal of neurology (01-03-2018)
    “…Background and purpose We have previously shown that patients with multiple sclerosis receiving immunomodulatory treatment have reduced seroprotection rates…”
    Get full text
    Journal Article
  4. 4

    Ischaemic stroke at a young age is a serious event - final results of a population-based long-term follow-up in Western Norway by Waje-Andreassen, U., Thomassen, L., Jusufovic, M., Power, K. N., Eide, G. E., Vedeler, C. A., Naess, H.

    Published in European journal of neurology (01-05-2013)
    “…Background and purpose Our population‐based long‐term follow‐up of young ischaemic stroke patients and controls showed 10‐fold increased mortality and fivefold…”
    Get full text
    Journal Article
  5. 5

    Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity by Panja, D., Vedeler, C. A., Schubert, M.

    Published in Neuropathology and applied neurobiology (01-02-2019)
    “…Aim Neurodegeneration is associated with dysfunction of calcium buffering capacity and thereby sustained cellular and mitochondrial calcium overload…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration by Bø, L, Vedeler, C A, Nyland, H, Trapp, B D, Mørk, S J

    Published in Multiple sclerosis (01-08-2003)
    “…The present study examined the extent and distribution of lymphocyte infiltration in demyelinated lesions in the cerebral cortex of multiple sclerosis (MS)…”
    Get full text
    Journal Article
  8. 8

    Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation by Johansen, Silje, Kråkenes, Jostein, Vedeler, C. A., Storstein, Anette Margrethe, Reikvam, Håkon

    Published in Case reports in immunology (10-09-2022)
    “…A woman with myelodysplastic syndrome (MDS) was treated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). 65 days after the transplantation,…”
    Get full text
    Journal Article
  9. 9

    IL-6: an early marker for outcome in acute ischemic stroke by Waje-Andreassen, U., Kråkenes, J., Ulvestad, E., Thomassen, L., Myhr, K.-M., Aarseth, J., Vedeler, C. A.

    Published in Acta neurologica Scandinavica (01-06-2005)
    “…Objectives –  Inflammation plays an important role in the pathophysiology of stroke. We correlated interleukin (IL)‐6, IL‐10, C‐reactive protein (CRP) and…”
    Get full text
    Journal Article
  10. 10

    Recommended diagnostic criteria for paraneoplastic neurological syndromes by Graus, F, Delattre, J Y, Antoine, J C, Dalmau, J, Giometto, B, Grisold, W, Honnorat, J, Smitt, P Sillevis, Vedeler, Ch, Verschuuren, J J G M, Vincent, A, Voltz, R

    “…Background: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and exclusion of other known causes of the neurological symptoms,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes by Storstein, A., Raspotnig, M., Vitaliani, R., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Vedeler, C. A.

    Published in Journal of neurology (01-05-2016)
    “…Prostate cancer is the most common cancer among American and European men. Nervous system affection caused by local tumor growth or osseous metastases are the…”
    Get full text
    Journal Article
  13. 13

    Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies by Storstein, A., Krossnes, B. K., Vedeler, C. A.

    Published in Acta neurologica Scandinavica (01-07-2009)
    “…Introduction –  Immunohistochemical studies of paraneoplastic cerebellar degeneration (PCD) are rare, and the findings vary. Materials and methods –  We…”
    Get full text
    Journal Article
  14. 14

    Management of paraneoplastic neurological syndromes: report of an EFNS Task Force by Vedeler, C. A., Antoine, J. C., Giometto, B., Graus, F., Grisold, W., Hart, I. K., Honnorat, J., Sillevis Smitt, P. A. E., Verschuuren, J. J. G. M., Voltz, R.

    Published in European journal of neurology (01-07-2006)
    “…Paraneoplastic neurological syndromes (PNS) are remote effects of cancer on the nervous system. An overview of the management of classical PNS, i.e…”
    Get full text
    Journal Article
  15. 15

    Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls by Kroksveen, A. C., Guldbrandsen, A., Vedeler, C., Myhr, K. M., Opsahl, J. A., Berven, F. S.

    Published in Acta neurologica Scandinavica (01-12-2012)
    “…Objectives The aim of the present study was to identify proteins in cerebrospinal fluid (CSF) with different abundance between patients with…”
    Get full text
    Journal Article
  16. 16

    Onconeural antibodies in patients with neurological symptoms: detection and clinical significance by Raspotnig, M., Vedeler, C. A., Storstein, A.

    Published in Acta neurologica Scandinavica (01-08-2011)
    “…Raspotnig M, Vedeler CA, Storstein A. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
Acta Neurol Scand:…”
    Get full text
    Journal Article Conference Proceeding
  17. 17
  18. 18
  19. 19

    Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories by Bader, L. I., Solberg, S. M., Kaada, S. H., Bolstad, N., Warren, D. J., Gavasso, S., Gjesdal, C. G., Vedeler, C. A.

    Published in Scandinavian journal of immunology (01-09-2017)
    “…Immunogenicity is a frequent cause of secondary non‐response to tumour necrosis factor (TNF) inhibitors. Drug level measurement and detection of antidrug…”
    Get full text
    Journal Article
  20. 20

    Systemic complement activation following human acute ischaemic stroke by PEDERSEN, E D., WAJE‐ANDREASSEN, U., VEDELER, C. A., AAMODT, G., MOLLNES, T. E.

    Published in Clinical and experimental immunology (01-07-2004)
    “…SUMMARY The brain tissue damage after stroke is mediated partly by inflammation induced by ischaemia–reperfusion injury where the complement system plays a…”
    Get full text
    Journal Article